Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Prothena Corporation plc (PRTA)

12.96   0.46 (3.68%) 12-12 16:00
Open: 12.46 Pre. Close: 12.5
High: 13 Low: 12.46
Volume: 163,202 Market Cap: 517M
Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.017 - 13.081 13.081 - 13.146
Low: 12.203 - 12.268 12.268 - 12.334
Close: 12.396 - 12.498 12.498 - 12.602

Technical analysis

as of: 2019-12-12 4:03:25 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.56     One year: 18.17
Support: Support1: 10.61    Support2: 8.94
Resistance: Resistance1: 13.32    Resistance2: 15.56
Pivot: 12.24
Moving Average: MA(5): 12.72     MA(20): 11.83
MA(100): 9.18     MA(250): 10.34
MACD: MACD(12,26): 0.86     Signal(9): 0.87
Stochastic oscillator: %K(14,3): 76.90     %D(3): 77.81
RSI: RSI(14): 70.71
52-week: High: 14.77  Low: 6.71  Change(%): 10.9
Average Vol(K): 3-Month: 19735  10-Days: 19346

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PRTA has closed below upper band by 20.3%. Bollinger Bands are 25.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Why Is Prothena (PRTA) Up 36.1% Since Last Earnings Report?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Brokerages Set Prothena Co. PLC (NASDAQ:PRTA) Target Price at $10.00
Prothena Co. PLC (NASDAQ:PRTA) has received an average recommendation of “Hold” from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. The average 1-year […]

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39.90
Shares Float (M) 25.37
% Held by Insiders 90.10
% Held by Institutions
Shares Short (K) 1740
Shares Short P. Month (K)

Stock Financials

EPS -1.970
Book Value (p.s.) 7.250
PEG Ratio 0.89
Profit Margin
Operating Margin -11546.01
Return on Assets (ttm) -11.1
Return on Equity (ttm) -25.0
Qtrly Rev. Growth -19.6
Gross Profit (p.s.) -2.512
Sales Per Share
EBITDA (p.s.) -2.126
Qtrly Earnings Growth
Operating Cash Flow (M) -59.73
Levered Free Cash Flow (M) -36.97

Stock Valuations

P/E -6.59
P/E Growth Ratio 0.04
P/BV 1.79
P/S 649.49
P/CF -8.68

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.